New Gene Repair Technique Promises Advances in Regenerative Medicine
Aug. 12, 2013 — Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria,
researchers from the Morgridge Institute for Research and Northwestern University have created an
efficient way to target and repair defective genes.
Writing August 12 in the Proceedings of the National Academy of Sciences, the team reports that the novel
technique is much simpler than previous methods and establishes the groundwork for major advances in
regenerative medicine, drug screening and biomedical research.
Zhonggang Hou of the Morgridge Institute's regenerative biology team and Yan Zhang of Northwestern
University served as first authors on the study; James Thomson, director of regenerative biology at the
Morgridge Institute, and Erik Sontheimer, professor of molecular biosciences at Northwestern University,
served as principal investigators.
"With this system, there is the potential to repair any genetic defect, including those responsible for some
forms of breast cancer, Parkinson's and other diseases," Hou said. "The fact that it can be applied to human
pluripotent stem cells opens the door for meaningful therapeutic applications."
Zhang said the Northwestern University team focused on Neisseria meningitidis bacteria because it is a
good source of the Cas9 protein needed for precisely cleaving damaged sections of DNA.
"We are able to guide this protein with different types of small RNA molecules, allowing us to carefully
remove, replace or correct problem genes," Zhang said. "This represents a step forward from other recent
technologies built upon proteins such as zinc finger nucleases and TALENs."
These previous gene correction methods required engineered proteins to help with the cutting. Hou said
scientists can synthesize RNA for the new process in as little as one to three days -- compared with the
weeks or months needed to engineer suitable proteins.
Thomson, who also serves as the James Kress Professor of Embryonic Stem Cell Biology at the University
of Wisconsin-Madison, a John D. MacArthur professor at UW-Madison's School of Medicine and Public
Health and a professor in the department of molecular, cellular and developmental biology at the University
of California, Santa Barbara, says the discovery holds many practical applications.
"Human pluripotent stem cells can proliferate indefinitely and they give rise to virtually all human cell types,
making them invaluable for regenerative medicine, drug screening and biomedical research," Thomson
says. "Our collaboration with the Northwestern team has taken us further toward realizing the full
potential of these cells because we can now manipulate their genomes in a precise, efficient manner."
Sontheimer, who serves as the Soretta and Henry Shapiro Research Professor of Molecular Biology with
Northwestern's department of molecular biosciences, Center for Genetic Medicine and the Robert H. Lurie
Comprehensive Cancer Center of Northwestern University, says the team's results also offer hopeful signs
about the safety of the technique.
"A major concern with previous methods involved inadvertent or off-target cleaving, raising issues about
the potential impact in regenerative medicine applications," he said. "Beyond overcoming the safety
obstacles, the system's ease of use will make what was once considered a difficult project into a routine
laboratory technique, catalyzing future research."
Also contributing to the study, which was supported by funding from sources including the National
Institutes of Health, the Wynn Foundation and the Morgridge Institute for Research, were Nicholas
Propson, Sara Howden and Li-Fang Chu from the Morgridge Institute for Research.
Story Source:
The above story is based on materials provided by University of Wisconsin-Madison. The original article was
written by Jennifer Sereno.
Aug. 12, 2013 — Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria,
researchers from the Morgridge Institute for Research and Northwestern University have created an
efficient way to target and repair defective genes.
Writing August 12 in the Proceedings of the National Academy of Sciences, the team reports that the novel
technique is much simpler than previous methods and establishes the groundwork for major advances in
regenerative medicine, drug screening and biomedical research.
Zhonggang Hou of the Morgridge Institute's regenerative biology team and Yan Zhang of Northwestern
University served as first authors on the study; James Thomson, director of regenerative biology at the
Morgridge Institute, and Erik Sontheimer, professor of molecular biosciences at Northwestern University,
served as principal investigators.
"With this system, there is the potential to repair any genetic defect, including those responsible for some
forms of breast cancer, Parkinson's and other diseases," Hou said. "The fact that it can be applied to human
pluripotent stem cells opens the door for meaningful therapeutic applications."
Zhang said the Northwestern University team focused on Neisseria meningitidis bacteria because it is a
good source of the Cas9 protein needed for precisely cleaving damaged sections of DNA.
"We are able to guide this protein with different types of small RNA molecules, allowing us to carefully
remove, replace or correct problem genes," Zhang said. "This represents a step forward from other recent
technologies built upon proteins such as zinc finger nucleases and TALENs."
These previous gene correction methods required engineered proteins to help with the cutting. Hou said
scientists can synthesize RNA for the new process in as little as one to three days -- compared with the
weeks or months needed to engineer suitable proteins.
Thomson, who also serves as the James Kress Professor of Embryonic Stem Cell Biology at the University
of Wisconsin-Madison, a John D. MacArthur professor at UW-Madison's School of Medicine and Public
Health and a professor in the department of molecular, cellular and developmental biology at the University
of California, Santa Barbara, says the discovery holds many practical applications.
"Human pluripotent stem cells can proliferate indefinitely and they give rise to virtually all human cell types,
making them invaluable for regenerative medicine, drug screening and biomedical research," Thomson
says. "Our collaboration with the Northwestern team has taken us further toward realizing the full
potential of these cells because we can now manipulate their genomes in a precise, efficient manner."
Sontheimer, who serves as the Soretta and Henry Shapiro Research Professor of Molecular Biology with
Northwestern's department of molecular biosciences, Center for Genetic Medicine and the Robert H. Lurie
Comprehensive Cancer Center of Northwestern University, says the team's results also offer hopeful signs
about the safety of the technique.
"A major concern with previous methods involved inadvertent or off-target cleaving, raising issues about
the potential impact in regenerative medicine applications," he said. "Beyond overcoming the safety
obstacles, the system's ease of use will make what was once considered a difficult project into a routine
laboratory technique, catalyzing future research."
Also contributing to the study, which was supported by funding from sources including the National
Institutes of Health, the Wynn Foundation and the Morgridge Institute for Research, were Nicholas
Propson, Sara Howden and Li-Fang Chu from the Morgridge Institute for Research.
Story Source:
The above story is based on materials provided by University of Wisconsin-Madison. The original article was
written by Jennifer Sereno.